Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 263864, 7 pages
http://dx.doi.org/10.1155/2015/263864
Research Article

Ethnic-Specific Genetic Association of Variants in the Corticotropin-Releasing Hormone Receptor 1 Gene with Nicotine Dependence

1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou 310009, China
2Department of Public Health Sciences, University of Virginia, Charlottesville, VA 22908, USA
3Department of Otolaryngology and Communicative Sciences, ACT Center for Tobacco Treatment, Education and Research, University of Mississippi Medical Center, Jackson, MS 39213, USA
4Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22904, USA

Received 23 September 2014; Accepted 5 January 2015

Academic Editor: Xueyuan Cao

Copyright © 2015 Xiujun Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, The World Health Report 2002, World Health Organization, 2002.
  2. WHO, Report on the Global Tobacco Epidemic, 2008: The MPOWER Package, World Health Organization, Geneva, Switzerland, 2008.
  3. J. Moxham, “Nicotine addiction,” British Medical Journal, vol. 320, no. 7232, pp. 391–392, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Branstetter, M. Mercincavage, G. Dino, and K. Horn, “Development and validation of a smoking expectancies measure for adolescents seeking to quit smoking,” Substance Abuse, 2014. View at Publisher · View at Google Scholar
  5. J. R. Hughes, S. B. Gulliver, J. W. Fenwick et al., “Smoking cessation among self-quitters,” Health Psychology, vol. 11, no. 5, pp. 331–334, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. Picciotto, “Nicotine as a modulator of behavior: beyond the inverted U,” Trends in Pharmacological Sciences, vol. 24, no. 9, pp. 493–499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. D. Li and M. Burmeister, “New insights into the genetics of addiction,” Nature Reviews Genetics, vol. 10, no. 4, pp. 225–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Bierut, “Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25,” Trends in Pharmacological Sciences, vol. 31, no. 1, pp. 46–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Goldman, G. Oroszi, and F. Ducci, “The genetics of addictions: uncovering the genes,” Nature Reviews Genetics, vol. 6, no. 7, pp. 521–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. N. Lessov-Schlaggar, M. L. Pergadia, T. V. Khroyan, and G. E. Swan, “Genetics of nicotine dependence and pharmacotherapy,” Biochemical Pharmacology, vol. 75, no. 1, pp. 178–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. B. Gabriel, S. F. Schaffner, H. Nguyen et al., “The structure of haplotype blocks in the human genome,” Science, vol. 296, no. 5576, pp. 2225–2229, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. Li, “Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses,” Human Genetics, vol. 123, no. 2, pp. 119–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Heath, P. A. F. Madden, W. S. Slutske, and N. G. Martin, “Personality and the inheritance of smoking behavior: a genetic perspective,” Behavior Genetics, vol. 25, no. 2, pp. 103–117, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Li, R. Cheng, J. Z. Ma, and G. E. Swan, “A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins,” Addiction, vol. 98, no. 1, pp. 23–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. H. Perrin, Y. Haas, J. E. Rivier, and W. W. Vale, “Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides,” Endocrinology, vol. 118, no. 3, pp. 1171–1179, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Chen, K. A. Lewis, M. H. Perrin, and W. W. Vale, “Expression cloning of a human corticotropin-releasing-factor receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 19, pp. 8967–8971, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. M.-A. Enoch, “Genetic influences on the development of alcoholism,” Current Psychiatry Reports, vol. 15, no. 11, article 412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. A. Briand and J. A. Blendy, “Molecular and genetic substrates linking stress and addiction,” Brain Research, vol. 1314, pp. 219–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. K. H. Skelton, D. A. Gutman, K. V. Thrivikraman, C. B. Nemeroff, and M. J. Owens, “The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal,” Psychopharmacology, vol. 192, no. 3, pp. 385–396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-S. Wang, W. Kamphuis, I. Huitinga, J.-N. Zhou, and D. F. Swaab, “Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances,” Molecular Psychiatry, vol. 13, no. 8, pp. 786–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhou, D. Proudnikov, V. Yuferov, and M. J. Kreek, “Drug-induced and genetic alterations in stress-responsive systems: implications for specific addictive diseases,” Brain Research, vol. 1314, pp. 235–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. R. True, H. Xian, J. F. Scherrer et al., “Common genetic vulnerability for nicotine and alcohol dependence in men,” Archives of General Psychiatry, vol. 56, no. 7, pp. 655–661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. K. O. Fagerstroem, “Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment,” Addictive Behaviors, vol. 3, no. 3-4, pp. 235–241, 1978. View at Publisher · View at Google Scholar · View at Scopus
  24. K. O. Fagerstrom, T. F. Heatherton, and L. T. Kozlowski, “Nicotine addiction and its assessment,” Ear, Nose & Throat Journal, vol. 69, no. 11, pp. 763–765, 1990. View at Google Scholar · View at Scopus
  25. M. D. Li, J. Beuten, J. Z. Ma et al., “Ethnic-and gender-specific association of the nicotinic acetylcholine receptor α4 subunit gene (CHRNA4) with nicotine dependence,” Human Molecular Genetics, vol. 14, no. 9, pp. 1211–1219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Beuten, T. J. Payne, J. Z. Ma, and M. D. Li, “Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations,” Neuropsychopharmacology, vol. 31, no. 3, pp. 675–684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Beuten, J. Z. Ma, T. J. Payne et al., “Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence,” The American Journal of Human Genetics, vol. 76, no. 5, pp. 859–864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. D. Li, Q. Xu, X.-Y. Lou, T. J. Payne, T. Niu, and J. Z. Ma, “Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans,” American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 153, no. 3, pp. 745–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Lange, D. DeMeo, E. K. Silverman, S. T. Weiss, and N. M. Laird, “PBAT: tools for family-based association studies,” The American Journal of Human Genetics, vol. 74, no. 2, pp. 367–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Horvath, X. Xu, S. L. Lake, E. K. Silverman, S. T. Weiss, and N. M. Laird, “Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics,” Genetic Epidemiology, vol. 26, no. 1, pp. 61–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. G. E. Swan, K. S. Hudmon, L. M. Jack et al., “Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 10, pp. 994–1005, 2003. View at Google Scholar · View at Scopus
  33. W. J. Kim, S. S. Sheen, T.-H. Kim et al., “Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD,” Respirology, vol. 14, no. 2, pp. 260–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Contoreggi, M. R. Lee, and G. Chrousos, “Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications,” Annals of the New York Academy of Sciences, vol. 1282, no. 1, pp. 107–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Liu, F. Zhu, G. Wang et al., “Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression,” Neuroscience Letters, vol. 404, no. 3, pp. 358–362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Liu, F. Zhu, G. Wang et al., “Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders,” Neuroscience Letters, vol. 414, no. 2, pp. 155–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Blomeyer, J. Treutlein, G. Esser, M. H. Schmidt, G. Schumann, and M. Laucht, “Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use,” Biological Psychiatry, vol. 63, no. 2, pp. 146–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Treutlein, C. Kissling, J. Frank et al., “Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples,” Molecular Psychiatry, vol. 11, no. 6, pp. 594–602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Ribbe, V. Ackermann, J. Schwitulla et al., “Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system,” Archives of General Psychiatry, vol. 68, no. 12, pp. 1247–1256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. C. H. Chen, N. Manz, Y. Tang et al., “Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence,” Alcoholism: Clinical and Experimental Research, vol. 34, no. 6, pp. 988–996, 2010. View at Publisher · View at Google Scholar · View at Scopus